Nine patients (33%) were classified as MEITL, 11 (41%) as ATLL, and seven (26%) as other (one EBV+ CD56+; three EBV+ CD56 negative TNKCL; two indolent TLPD; one anaplastic large cell lymphoma (ALCL)). The gene discussed is NCAM1; the disease is anaplastic large cell lymphoma.